Drug Type Chemical drugs |
Synonyms AM 1125, AM1125 |
Target |
Action antagonists |
Mechanism 5-HT2B receptor antagonists(Serotonin 2b (5-HT2b) receptor antagonists) |
Active Indication- |
Inactive Indication |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Scleroderma, Systemic | Preclinical | Sweden | 15 Jun 2017 |





